1.Prevalence and risk factors of lower limb deep vein thrombosis after hip replacement in middle-aged and elderly patients
International Journal of Biomedical Engineering 2022;45(4):312-316
Objective:To investigate the incidence of lower extremity deep vein thrombosis (DVT) after hip replacement surgery in middle-aged and elderly patients and to explore the risk factors.Methods:A total of 121 middle-aged and elderly patients who underwent hip replacement in the Tianjin People's Hospital from January 1, 2018 to December 31, 2020 were collected for analysis. The basic characteristics of the patients included were statistically described by univariate and multivariate logistic regression analysis.Results:There were 98 male patients and 23 female patients, with an average age of 59.55±9.53 years. 51 patients developed postoperative DVT of the lower limbs, with an incidence of 42.1%. Older age ( OR=1.129, 95% CI=1.013-1.239), body mass index (BMI, kg/m 2) ≥24 ( OR=1.493, 95% CI=1.066-2.314), history of diabetes ( OR=1.293, 95% CI=1.114-2.094), and long postoperative hospital stay ( OR=1.203, 95% CI=1.056-1.377) were risk factors. Conclusions:The risk of lower extremity DVT after hip replacement surgery was higher in middle-aged and elderly patients. In clinical practice, we should pay attention to risk factors and focus on key groups to prevent the occurrence and development of lower extremity DVT.
2.The expression and correlation of HMGB1 and VEGF protein in laryngeal squamous cell carcinoma.
Yong LIU ; Yuanzhenk QIU ; Xin ZHANG ; Yongquan TIAN ; Donghai HUANG ; Xiaojuan ZHOU ; Pingqing TAN ; Changyun YU ; Lin QI ; Jianyun XIAO
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2011;25(6):265-269
OBJECTIVE:
To investigate the expression and biological significance of HMGB1 and VEGF protein in tissue specimens of laryngeal squamous cell carcinoma (LSCC), and further study the correlation between HMGB1 and VEGF protein.
METHOD:
The expression of HMGB1 and VEGF protein was evaluated by immunohistochemical staining in 69 cases of LSCC specimens and 15 cases of adjacent epithelial tissue samples, and futher correlated with clinicopathologic parameters.
RESULT:
The positive rates of HMGB1 and VEGF in LSCC tissues were significantly higher than those in adjacent non-cancerous mucosa (P < 0.01), and the expression of these two marks was closely correlated with clinical stage (P < 0.05) and metastasis (P < 0.05) in LSCC. While the expression of HMGB1 and VEGF had no significant correlations with age, sex, histological differentiation and tumor site (P > 0. 05). There was a positive correlation between the expression of HMGB1 and VEGF (P < 0.05). The Kaplan-Meier survival analysis showed that patients with strong expression of HMGB1 or VEGF had poorer overall survival compared with that in patients with relative low HMGB1 or VEGF expression (P < 0.05). Multivariate COX regression analysis revealed that both lymph node metastasis and HMGB1 expression were independent prognostic factors for patients with LSCC.
CONCLUSION
This study demonstrated that HMGB1 and VEGF protein overexpression were closely associated with clinical stage, metastasis and poorer prognosis in patients with LSCC. Increased expression of these two proteins in LSCC suggested that HMGB1 and VEGF might play a critical role in the initiation and progression of LSCC.
Adult
;
Aged
;
Aged, 80 and over
;
Carcinoma, Squamous Cell
;
metabolism
;
pathology
;
Female
;
HMGB1 Protein
;
metabolism
;
Humans
;
Laryngeal Neoplasms
;
metabolism
;
pathology
;
Lymphatic Metastasis
;
Male
;
Middle Aged
;
Neoplasm Staging
;
Vascular Endothelial Growth Factor A
;
metabolism
3.Positive effects of Xuebijing injection on intestinal microbiota and metabolite spectrum in septic rats.
Xianfei DING ; Yangyang YUAN ; Ran TONG ; Kun WANG ; Shaohua LIU ; Xueyan QI ; Xiaojuan ZHANG ; Jiebin CAO ; Tongwen SUN
Chinese Critical Care Medicine 2023;35(7):690-695
OBJECTIVE:
To explore the effect of Xuebijing injection on inflammation in sepsis by regulating intestinal microbiota and its metabolites.
METHODS:
A total of 45 male Sprague-Dawley (SD) rats were randomly divided into Sham operation group (Sham group), cecal ligation and perforation (CLP) induced sepsis group (CLP group), and Xuebijing intervention group (XBJ group, 4 mL/kg Xuebijing injection was injected intraperitoneally at 1 hour after CLP), with 15 rats in each group. The survival of rats was observed at 24 hours after operation and sacrificed. Feces were collected for 16S rRNA gene sequencing and liquid chromatography-mass spectrometry (LC-MS) analysis.
RESULTS:
At 24 hours after operation, all rats in the Sham group survived, the mortality of rats in the XBJ group was lower than that in the CLP group [47% (7/15) vs. 60% (9/15), P > 0.05]. Compared with the Sham group, the diversity of gut microbiota in the CLP group decreased, the dominant flora changed, and the abundance of inflammation-related flora increased. Xuebijing improved the changes in gut microbiota caused by sepsis, and α diversity showed an increasing trend (Ace index: 406.0±22.5 vs. 363.2±38.2, Chao1 index: 409.7±21.8 vs. 362.4±42.5, both P > 0.05). Restrictive constrained principal coordinate analysis (cPCoA) showed a high similarity in gut microbiota among the same group of rats. The CLP group was dominated by Bacteroidetes, while the Sham and XBJ groups were dominated by Firmicutes. In addition, compared with the CLP group, Xuebijing treatment increased the abundance of beneficial bacteria in septic rats, such as Verrucomicrobia, Akkermansia and Lactobacillus. LC-MS and orthogonal partial least squares discriminant analysis (OPLS-DA) showed that there were 12 main differential metabolites among the three groups, and there were certain correlations between these metabolites, which were related to amino acid and lipid metabolism. Correlation analysis showed a significant correlation between changes in metabolites and microbial communities.
CONCLUSIONS
Xuebijing can improve the survival rate of septic rats, regulate the composition of intestinal flora and related metabolites, which provides a new pathophysiological mechanism for Xuebijing in the treatment of sepsis.
Rats
;
Male
;
Animals
;
Rats, Sprague-Dawley
;
Gastrointestinal Microbiome
;
RNA, Ribosomal, 16S
;
Sepsis/metabolism*
;
Inflammation